相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Antiangiogenic gene therapy with soluble VEGF-receptors-1,-2 and-3 together with paclitaxel prolongs survival of mice with human ovarian carcinoma
Minna Sopo et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Adrenomedullin expression in epithelial ovarian cancers and promotes HO8910 cell migration associated with upregulating integrin α5β1 and phosphorylating FAK and paxillin
Boya Deng et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2012)
Adrenomedullin and calcitonin gene-related peptide receptors in endocrine-related cancers: opportunities and challenges
Debbie L. Hay et al.
ENDOCRINE-RELATED CANCER (2011)
Angiogenic signaling aberrantly induced by tumor hypoxia
Keizo Takenaga
FRONTIERS IN BIOSCIENCE-LANDMARK (2011)
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
G. L. Semenza
ONCOGENE (2010)
Clinical and biological significance of angiogenesis and lymphangiogenesis in colorectal cancer
J. Gao et al.
DIGESTIVE AND LIVER DISEASE (2009)
Basic fibroblast growth factor upregulates adrenomedullin expression in ovarian epithelial carcinoma cells via JNK-AP-1 pathway
Yi Zhang et al.
REGULATORY PEPTIDES (2009)
Adrenomedullin is expressed in pancreatic cancer and stimulates cell proliferation and invasion in an autocrine manner via the adrenomedullin receptor, ADMR
Vijaya Ramachandran et al.
CANCER RESEARCH (2007)
Adrenomedullin increases the expression of calcitonin-like receptor and receptor activity modifying protein 2 mRNA in human microvascular endothelial cells
Nele Schwarz et al.
JOURNAL OF ENDOCRINOLOGY (2006)
The proinflammatory cytokine interleukin 1β and hypoxia cooperatively induce the expression of adrenomedullin in ovarian carcinoma cells through hypoxia inducible factor 1 activation
S Frede et al.
CANCER RESEARCH (2005)
Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis
DJ Hicklin et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
HIFs and tumors -: causes and consequences
G Höpfl et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2004)
Vascular endothelial growth factor as a target for anticancer therapy
N Ferrara
ONCOLOGIST (2004)
Adrenomedullin antagonist suppresses in vivo growth of human pancreatic cancer cells in SCID mice by suppressing angiogenesis
T Ishikawa et al.
ONCOGENE (2003)
VEGF and HIF-1 alpha expression are increased in advanced stages of epithelial ovarian cancer
C Wong et al.
GYNECOLOGIC ONCOLOGY (2003)
Involvement of adrenomedullin induced by hypoxia in angiogenesis in human renal cell carcinoma
Y Fujita et al.
INTERNATIONAL JOURNAL OF UROLOGY (2002)
Neutralization of adrenomedullin inhibits the growth of human glioblastoma cell lines in vitro and suppresses tumor xenograft growth in vivo
L Ouafik et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Stabilization of vascular endothelial growth factor mRNA by hypoxia-inducible factor 1
LX Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Adrenomedullin inhibits hypoxic cell death by upregulation of Bcl-2 in endometrial cancer cells: a possible promotion mechanism for tumour growth
MK Oehler et al.
ONCOGENE (2001)
Adrenomedullin is an autocrine regulator of endothelial growth in human endometrium
LL Nikitenko et al.
MOLECULAR HUMAN REPRODUCTION (2000)